Paper40109752
Chemical Probes for Studying the Eukaryotic Translation Initiation Factor 4E (eIF4E)-Regulated Translatome in Cancer.
O'Rourke RL and 1 other. ACS Pharmacol Transl Sci, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Chemical Probes for Studying the Eukaryotic Translation Initiation Factor 4E (eIF4E)-Regulated Translatome in Cancer. Papers, record 40109752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40109752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemical Probes for Studying the Eukaryotic Translation Initiation Factor 4E (eIF4E)-Regulated Translatome in Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 GM132342 | NIGMS NIH HHS | United States | R01GM132342 | PubMed and NIH | NIH RePORTER |
| R35 GM153185 | NIGMS NIH HHS | United States | R35GM153185 | PubMed and NIH | NIH RePORTER |
References141
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29649496 | The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold. | Antiviral Res | 2018 | https://conductscience.org/library/papers/29649496 | PubMed |
| 2 | 28814434 | Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28814434 | PubMed |
| 3 | 38913822 | Covalent Inhibitors: To Infinity and Beyond. | J Med Chem | 2024 | https://conductscience.org/library/papers/38913822 | PubMed |
| 4 | 35717238 | Treatment with eFT-508 increases chemosensitivity in breast cancer cells by modulating the tumor microenvironment. | J Transl Med | 2022 | https://conductscience.org/library/papers/35717238 | PubMed |
| 5 | 24401275 | MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas. | J Clin Invest | 2014 | https://conductscience.org/library/papers/24401275 | PubMed |
| 6 | 22552098 | A unifying model for mTORC1-mediated regulation of mRNA translation. | Nature | 2012 | https://conductscience.org/library/papers/22552098 | PubMed |
| 7 | 34508258 | The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. | Nat Rev Clin Oncol | 2022 | https://conductscience.org/library/papers/34508258 | PubMed |
| 8 | 39811141 | Second-Generation Cap Analogue Prodrugs for Targeting Aberrant Eukaryotic Translation Initiation Factor 4E Activity in Cancer. | ACS Med Chem Lett | 2025 | https://conductscience.org/library/papers/39811141 | PubMed |
| 9 | 34645806 | Cancer gene mutation frequencies for the U.S. population. | Nat Commun | 2021 | https://conductscience.org/library/papers/34645806 | PubMed |
| 10 | 23542178 | Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. | Oncogene | 2014 | https://conductscience.org/library/papers/23542178 | PubMed |
| 11 | 20131845 | New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. | J Med Chem | 2010 | https://conductscience.org/library/papers/20131845 | PubMed |
| 12 | 26984228 | nanoCAGE reveals 5' UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs. | Genome Res | 2016 | https://conductscience.org/library/papers/26984228 | PubMed |
| 13 | 12434151 | Structural basis of m7GpppG binding to the nuclear cap-binding protein complex. | Nat Struct Biol | 2002 | https://conductscience.org/library/papers/12434151 | PubMed |
| 14 | 36325577 | Translational alterations in pancreatic cancer: a central role for the integrated stress response. | NAR Cancer | 2022 | https://conductscience.org/library/papers/36325577 | PubMed |
| 15 | 33490040 | Overview of Biologically Active Nucleoside Phosphonates. | Front Chem | 2020 | https://conductscience.org/library/papers/33490040 | PubMed |
| 16 | 21233335 | Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases. | Cancer Res | 2011 | https://conductscience.org/library/papers/21233335 | PubMed |
| 17 | 22458568 | Structure-guided design, synthesis, and evaluation of guanine-derived inhibitors of the eIF4E mRNA-cap interaction. | J Med Chem | 2012 | https://conductscience.org/library/papers/22458568 | PubMed |
| 18 | 31056462 | Chemoproteomic Profiling Uncovers CDK4-Mediated Phosphorylation of the Translational Suppressor 4E-BP1. | Cell Chem Biol | 2019 | https://conductscience.org/library/papers/31056462 | PubMed |
| 19 | 9200613 | Cocrystal structure of the messenger RNA 5' cap-binding protein (eIF4E) bound to 7-methyl-GDP. | Cell | 1997 | https://conductscience.org/library/papers/9200613 | PubMed |
| 20 | 21191102 | Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21191102 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42725432 | Altered neuronal start codon stringency favors cap-independent repeat-associated non-AUG translation. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42725432 | PubMed |
| 42424620 | Benzoxaboroles Are Structurally Unique Binders of Eukaryotic Translation Initiation Factor 4E. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/42424620 | PubMed |
| 41984598 | Therapeutic targeting of the eIF4E cap-binding domain reveals control of lineage fate in prostate cancer. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41984598 | PubMed |
| 41809015 | Benzoxaboroles are structurally unique binders of eukaryotic translation initiation factor 4E. | bioRxiv | 2026 | https://conductscience.org/library/papers/41809015 | PubMed |
| 40805230 | Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805230 | PubMed |
| 40770919 | CRISPR RiPCA for Investigating eIF4E-m7GpppX Capped mRNA Interactions. | ACS Chem Biol | 2025 | https://conductscience.org/library/papers/40770919 | PubMed |
| 40544238 | HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progression. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40544238 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| EIF4E | 1977 | PubTator's text mining | https://conductscience.org/library/genes/1977 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| ZHX2 | 22882 | PubTator's text mining | https://conductscience.org/library/genes/22882 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40109752
GET https://conductscience.org/api/papers/v1/40109752/references?page=2